IndraLab

Statements


| 1 2

reach
"Abnormalities in the PI3K and Akt signaling pathway deregulation of C/EBP-alpha and its partner PPAR-gamma, and the interaction between calreticulin (CRT) and CD47 are also promising therapeutic targets."

sparser
"Abnormalities in the PI3K/Akt signaling pathway deregulation of C/EBP-α and its partner PPAR-γ , and the interaction between calreticulin (CRT) and CD47 are also promising therapeutic targets."

sparser
"In DMM, calreticulin expression was not statistically associated with CD47 expression levels ( xref )."